Related references
Note: Only part of the references are listed.Thirteen compounds promoting oligodendrocyte progenitor cell differentiation and remyelination for treating multiple sclerosis: WO2010054307
Philippe Taupin
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Jan Ottervald et al.
JOURNAL OF PROTEOMICS (2010)
Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis
Pal Berg-Hansen et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F. Sellebjerg et al.
NEUROLOGY (2009)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
Training neural network classifiers for medical decision making: The effects of imbalanced datasets on classification performance
Maciej A. Mazurowski et al.
NEURAL NETWORKS (2008)
Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
Thomas Berger et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis
Lisa K. Peterson et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis
Michele Fiorini et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
The spectrum of multiple sclerosis and treatment decisions
A Siva
CLINICAL NEUROLOGY AND NEUROSURGERY (2006)
Machine learning in bioinformatics
Pedro Larranaga et al.
BRIEFINGS IN BIOINFORMATICS (2006)
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis
PH Lalive et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Insights into the molecular pathogenesis of progression in multiple sclerosis - Potential implications for future therapies
J Imitola et al.
ARCHIVES OF NEUROLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Tau, phospho-tau, and S-100B in the cerebrospinal fluid of children with multiple sclerosis
K Rostasy et al.
JOURNAL OF CHILD NEUROLOGY (2005)
αB-crystallin in cerebrospinal fluid of patients with multiple sclerosis
B Stoevring et al.
CLINICA CHIMICA ACTA (2005)
Computational protein biomarker prediction: a case study for prostate cancer
M Wagner et al.
BMC BIOINFORMATICS (2004)
Comparison of protein precipitation methods for sample preparation prior to proteomic analysis
L Jiang et al.
JOURNAL OF CHROMATOGRAPHY A (2004)
Development of biomarkers in multiple sclerosis
B Bielekova et al.
BRAIN (2004)
Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients
D Dumont et al.
PROTEOMICS (2004)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Tau protein in cerebrospinal fluid:: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
A Martínez-Yélamos et al.
NEUROSCIENCE LETTERS (2004)
Proteomic analysis of multiple sclerosis cerebrospinal fluid
BN Hammack et al.
MULTIPLE SCLEROSIS (2004)
Myelin basic protein - diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis
G Harauz et al.
MICRON (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
T Berger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders
M Reindl et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Biological indicators of the neurodegenerative phase of multiple sclerosis
M Zaffaroni
NEUROLOGICAL SCIENCES (2003)
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
A Petzold et al.
BRAIN (2002)
A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis
AJ Chamczuk et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Increased cerebrospinal fluid tau protein in multiple sclerosis
E Kapaki et al.
EUROPEAN NEUROLOGY (2000)
Share Paper
